Company Dossier
CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock
2 strict evidence familiesEvidence GapValuation Unverified
Score stack
The dossier explains decomposition rather than presenting one opaque score.
Structural bottleneck91
Evidence quality91
Financial conversion99
Valuation risk state18
Supports / blocks
Supports
- Strict Sec evidence
- Strict Government Contract evidence
Blocks conclusion
- Clinical Trials
- Valuation source missing